Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group.

Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4361-9. [Epub ahead of print] Review.

PMID:
28770322
2.

Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

Perreault L, Færch K, Gregg EW.

Curr Diab Rep. 2017 Sep;17(9):77. doi: 10.1007/s11892-017-0899-7. Review.

PMID:
28766246
3.

EMPA-REG OUTCOME: The Endocrinologist's Point of View.

Perreault L.

Am J Cardiol. 2017 Jul 1;120(1S):S48-S52. doi: 10.1016/j.amjcard.2017.05.010. Epub 2017 May 17. Review.

4.

EMPA-REG OUTCOME: The Endocrinologist's Point of View.

Perreault L.

Am J Med. 2017 Jun;130(6S):S51-S56. doi: 10.1016/j.amjmed.2017.04.005.

5.

Functionalization of Mesoporous Carbon Materials for Selective Separation of Lanthanides under Acidic Conditions.

Perreault LL, Giret S, Gagnon M, Florek J, Larivière D, Kleitz F.

ACS Appl Mater Interfaces. 2017 Apr 5;9(13):12003-12012. doi: 10.1021/acsami.6b16650. Epub 2017 Mar 27.

PMID:
28271880
6.

Crossing kingdoms: Using decellularized plants as perfusable tissue engineering scaffolds.

Gershlak JR, Hernandez S, Fontana G, Perreault LR, Hansen KJ, Larson SA, Binder BY, Dolivo DM, Yang T, Dominko T, Rolle MW, Weathers PJ, Medina-Bolivar F, Cramer CL, Murphy WL, Gaudette GR.

Biomaterials. 2017 May;125:13-22. doi: 10.1016/j.biomaterials.2017.02.011. Epub 2017 Feb 10.

7.

Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2017 Mar;68:184-186. doi: 10.1016/j.metabol.2016.11.007. Epub 2017 Jan 5. No abstract available.

PMID:
28065437
8.

Functional Effects of Delivering Human Mesenchymal Stem Cell-Seeded Biological Sutures to an Infarcted Heart.

Hansen KJ, Favreau JT, Guyette JP, Tao ZW, Coffin ST, Cunha-Gavidia A, D'Amore B, Perreault LR, Fitzpatrick JP, DeMartino A, Gaudette GR.

Biores Open Access. 2016 Aug 1;5(1):249-60. doi: 10.1089/biores.2016.0026. eCollection 2016.

9.

Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Goldberg RB, Temprosa M, Mele L, Orchard T, Mather K, Bray G, Horton E, Kitabchi A, Krakoff J, Marcovina S, Perreault L, White N; Diabetes Prevention Program Research Group.

Metabolism. 2016 May;65(5):764-75. doi: 10.1016/j.metabol.2015.11.011. Epub 2015 Dec 2.

10.

Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans.

Newsom SA, Brozinick JT, Kiseljak-Vassiliades K, Strauss AN, Bacon SD, Kerege AA, Bui HH, Sanders P, Siddall P, Wei T, Thomas M, Kuo MS, Nemkov T, D'Alessandro A, Hansen KC, Perreault L, Bergman BC.

J Appl Physiol (1985). 2016 Jun 1;120(11):1355-63. doi: 10.1152/japplphysiol.00664.2015. Epub 2016 Mar 31.

11.

Dietary Fatty Acids Differentially Associate with Fasting Versus 2-Hour Glucose Homeostasis: Implications for The Management of Subtypes of Prediabetes.

Guess N, Perreault L, Kerege A, Strauss A, Bergman BC.

PLoS One. 2016 Mar 21;11(3):e0150148. doi: 10.1371/journal.pone.0150148. eCollection 2016.

12.

Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease.

Su W, Chen F, Dall TM, Iacobucci W, Perreault L.

Prev Chronic Dis. 2016 Jan 28;13:E13. doi: 10.5888/pcd13.150357.

13.

Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans.

Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, Sanders P, Siddall P, Wei T, Thomas MK, Kuo MS, Perreault L.

Diabetologia. 2016 Apr;59(4):785-98. doi: 10.1007/s00125-015-3850-y. Epub 2016 Jan 6.

PMID:
26739815
14.

Biomarkers of Ectopic Fat Deposition: The Next Frontier in Serum Lipidomics.

Perreault L, Starling AP, Glueck D, Brozinick JT, Sanders P, Siddall P, Kuo MS, Dabelea D, Bergman BC.

J Clin Endocrinol Metab. 2016 Jan;101(1):176-82. doi: 10.1210/jc.2015-3213. Epub 2015 Nov 17.

15.

Morning Circadian Misalignment during Short Sleep Duration Impacts Insulin Sensitivity.

Eckel RH, Depner CM, Perreault L, Markwald RR, Smith MR, McHill AW, Higgins J, Melanson EL, Wright KP Jr.

Curr Biol. 2015 Nov 16;25(22):3004-10. doi: 10.1016/j.cub.2015.10.011. Epub 2015 Nov 5.

16.

Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants.

Hivert MF, Christophi CA, Franks PW, Jablonski KA, Ehrmann DA, Kahn SE, Horton ES, Pollin TI, Mather KJ, Perreault L, Barrett-Connor E, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetes. 2016 Feb;65(2):520-6. doi: 10.2337/db15-0950. Epub 2015 Nov 2.

17.

Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.

Bergman BC, Brozinick JT, Strauss A, Bacon S, Kerege A, Bui HH, Sanders P, Siddall P, Kuo MS, Perreault L.

Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E398-408. doi: 10.1152/ajpendo.00134.2015. Epub 2015 Jun 30.

18.

Modeling the clinical and economic implications of obesity using microsimulation.

Su W, Huang J, Chen F, Iacobucci W, Mocarski M, Dall TM, Perreault L.

J Med Econ. 2015;18(11):886-97. doi: 10.3111/13696998.2015.1058805. Epub 2015 Aug 13.

PMID:
26057567
19.

Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Kim C, Christophi CA, Goldberg RB, Perreault L, Dabelea D, Marcovina SM, Pi-Sunyer X, Barrett-Connor E.

Diabet Med. 2016 Jan;33(1):32-8. doi: 10.1111/dme.12799. Epub 2015 May 29.

20.

Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study.

Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group.

Psychosom Med. 2015 Apr;77(3):303-10. doi: 10.1097/PSY.0000000000000156.

Supplemental Content

Loading ...
Support Center